slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 20,431-20,460
Pages 885
Rows per page 30
Arc
20,431-20,460 of 26,550
36
The slide shows a 'Triage Tool' interface. On the left is a process flow diagram (Tech Approach -> Predict -> Triage -> TPA -> Assay) with 'Triage' highlighted.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
37
The slide uses a vertical process flow on the left to indicate the current stage (TPA) within a larger drug discovery pipeline.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
38
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
39
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
40
Uses a circular diagram to represent the feedback loop between lab work and data integration.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
41
The chart uses a swimlane-style visualization to show progress across drug discovery stages (Target ID to Phase III).BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
42
Includes a clinical photograph of the condition.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
43
Includes a biological mechanism diagram showing NGF, BDNF, and NTF-3 binding to TrkA, TrkB, and TrkC receptors.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
44
The slide uses a complex biological illustration to map specific receptor pathways to cellular mechanisms in AD skin.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
45
Includes data on T-cell activation inhibition, sensory neuron activation, and mouse ear inflammation reduction.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
46
The slide uses a process flow diagram to illustrate an adaptive clinical trial design.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
47
The slide uses a flow-chart to illustrate an adaptive clinical trial design.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
48
Includes specific caveats regarding small sample size and short duration.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
49
The slide outlines a clinical trial process flow with specific durations and patient ratios.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
50
The slide uses a visual treatment flow diagram to contrast current and future treatment options.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
51
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
52
Includes a process diagram for biopsy analysis and a market segmentation breakdown.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
53
The slide demonstrates the inhibitory effect of anti-TNF monoclonal antibodies on cytokine release.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
54
The slide displays protein phosphorylation intensity across various markers for healthy vs. inflamed tissue.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
55
The slide contains four dose-response curves (a-d) and two box-and-whisker plots (e-f) showing cytokine levels in patient biopsies.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
56
The slide outlines a drug discovery pipeline starting from a biological question, moving through computational target identification, and ending with experimental validation.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
57
The slide uses a combination of a biological pathway diagram, scatter plots for differential expression, and a line chart for tissue-specific expression.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
58
The slide uses a process diagram to explain the experimental setup and bar charts to show the efficacy of the compound in reducing IL-6 and IL-8 levels.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
59
The slide uses a causal flow diagram to link PDE10 inhibition to therapeutic outcomes in IBD.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
60
The slide uses a combination of a horizontal timeline graphic and three vertical columns detailing specific development phases.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
61
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
62
The chart uses a Gantt-like structure to represent drug development stages (Target ID to Phase III).BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
63
The slide uses a process flow diagram to illustrate the integration of AI-driven precision medicine into the standard pharmaceutical R&D lifecycle.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
64
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
65
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit